News tagged with drug development

Vimizim approved for rare childhood disorder

(HealthDay)—Vimizim (elosulfase alfa) has been approved by the U.S. Food and Drug Administration to treat a rare childhood disorder called Mucopolysaccharidosis Type IVA, also known as Morquio A syndrome.

Feb 17, 2014
popularity not rated yet | comments 0

Classification system for bladder cancer prognosis

Researchers at Lund University have developed a classification system to determine the prognosis for bladder cancer. It is hoped that this will prove useful for future bladder cancer research and drug development.

Jan 29, 2014
popularity 5 / 5 (1) | comments 0